eLife

eLife is a unique collaboration between funders and practitioners of research to communicate influential discoveries in the life and biomedical sciences in the most effective way. It is launched with support from the Howard Hughes Medical Institute, the Wellcome Trust, and the Max Planck Society in November 2012. eLife represents a new model of scientific publishing, designed to meet the needs of scientists in life sciences and biomedicine in a better way. This includes free, immediate, online access to scientific articles; rapid, fair, and constructive review; and innovation in content presentation – in short, a journal for scientists, run by scientists. Initial decisions are made by eLife’s senior editors, and, if a submission is selected for further assessment, full peer review is overseen by eLife’s 175-member board of reviewing editors. The reviewing editor and reviewers consult once peer review comments are submitted, and provide a consolidated list of instructions to authors – eliminating unnecessary and time-consuming rounds of revision.

Publisher
eLife Sciences Publications, Ltd
Some content from Wikipedia, licensed under CC BY-SA

Chemist has designs on drug-resistant breast cancer

Dr. Jung-Mo Ahn, associate professor of chemistry and biochemistry at The University of Texas at Dallas, has designed a small molecule that could help breast cancer patients for whom current treatments no longer work.

Nov 09, 2017
popularity3 comments 1

New blood test developed to diagnose ovarian cancer

Investigators from Brigham and Women's Hospital and Dana-Farber Cancer Institute are leveraging the power of artificial intelligence to develop a new technique to detect ovarian cancer early and accurately. The team has identified ...

Oct 31, 2017
popularity1585 comments 0